EXCAVATIONS AT THE DARBAND-I RANIA PASS, KURDISTAN REGION OF IRAQ: REPORT ON THE 2018-2021 SEASONS
Iraq · 10.07.2026 · 1-32
DOI: 10.1017/irq.2026.10040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraq, online erschienen am 10.07.2026. Verfasst von John MacGinnis und 5 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article presents the results of the 2018–2021 seasons of excavation undertaken at the Darband-i Rania pass in the Kurdistan Region of Iraq. Fieldwork at Qalatga Darband saw the completion of excavation of the monumental fortified manor together with the geophysical mapping of the square fort and other areas of the site. At the Assyrian fortress of Usu Aska, excavation of two areas of utilitarian architecture was supported by a full programme of environmental sampling, while the defensive wall was articulated in multiple locations; in one of these the need for repeated rebuilding is interpreted as due to damage caused by earthquakes. Operations at Murad Rasu concentrated on investigating the badly eroded remains of a monumental mudbrick building now dated to the late third or the early second millennium B.C.
Zitieren
APA
MacGinnis, J., Dusting, A., Kertai, D., Matney, T., Petersen, A., & Ahmad, M. (2026). EXCAVATIONS AT THE DARBAND-I RANIA PASS, KURDISTAN REGION OF IRAQ: REPORT ON THE 2018-2021 SEASONS. Iraq, 1-32. https://doi.org/10.1017/irq.2026.10040
Vancouver
MacGinnis J, Dusting A, Kertai D, Matney T, Petersen A, Ahmad M. EXCAVATIONS AT THE DARBAND-I RANIA PASS, KURDISTAN REGION OF IRAQ: REPORT ON THE 2018-2021 SEASONS. Iraq. 2026:1-32. doi:10.1017/irq.2026.10040
BibTeX
@article{MacGinnis2026,
author = {MacGinnis, John and Dusting, Amanda and Kertai, David and Matney, Timothy and Petersen, Andrew and Ahmad, Mustafa},
title = {EXCAVATIONS AT THE DARBAND-I RANIA PASS, KURDISTAN REGION OF IRAQ: REPORT ON THE 2018-2021 SEASONS},
journal = {Iraq},
year = {2026},
pages = {1--32},
doi = {10.1017/irq.2026.10040}
}
EUVIMED